The best part of this, I can sit back later today and read the inevitable expert negative commentary, from the same people, who in addition to being experts in 1) cellular medicine and drug approval are also 2) experts in global financing!
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility, page-5
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.28 |
Change
-0.030(1.30%) |
Mkt cap ! $2.918B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.39 | $2.24 | $13.10M | 5.680M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 44474 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 30176 | 3 |
View Market Depth
| Last trade - 16.17pm 22/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |